{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:04:32Z","timestamp":1793239472385,"version":"4.5.0"},"reference-count":73,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Bacterial infections are a major cause of mortality and morbidity in humans throughout\nthe world. Infections due to resistant bacterial strains such as methicillin-resistant Staphyloccocusaureus\nvancomycin, resistant Enterococci, Klebsiella pneumoniae, Staphylococcus aureus,\nand Mycobacterium are alarming. Hence the development of new antibacterial agents, which act\nvia a novel mechanism of action, became a priority in antibacterial research. One such approach\nto overcome bacterial resistance is to target novel protein and develop antibacterial agents that act\nvia different mechanisms of action. Bacterial GlmU is one such bifunctional enzyme that catalyzes\nthe two consecutive reactions during the biosynthesis of uridine 5\u2032-diphospho-Nacetylglucosamine,\nan essential precursor for the biosynthesis of bacterial cell wall peptidoglycan.\nThis enzyme comprises two distinct active sites; acetyltransferase and uridyltransferase and both\nthese active sites act independently during catalytic reactions. GlmU is considered an attractive\ntarget for the design and development of newer antibacterial agents due to its important role in\nbacterial cell wall synthesis and the absence of comparable enzymes in humans. Availability of\nthree dimensions X-crystallographic structures of GlmU and their known catalytic mechanism\nfrom different bacterial strains have instigated research efforts for the development of novel antibacterial\nagents. Several GlmU inhibitors belonging to different chemical classes like 2-\nphenylbenzofuran derivative, quinazolines, aminoquinazolines, sulfonamides, arylsulfonamide,\nD-glucopyranoside 6-phosphates, terreic acid, iodoacetamide, N-ethyl maleimide, and Nethylmaleimide\netc., have been reported in the literature. In the present review, we present an update\non GlmU inhibitors and their associated antibacterial activities. This review may be useful\nfor the design and development of novel GlmU inhibitors with potent antibacterial activity.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389557522666220817114445","type":"journal-article","created":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T12:00:01Z","timestamp":1660824001000},"page":"343-360","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["GlmU Inhibitors as Promising Antibacterial Agents: A Review"],"prefix":"10.2174","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9770-9371","authenticated-orcid":true,"given":"Mohammed Afzal","family":"Azam","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education and Research,\nOoty, Nilgiris, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagarjuna","family":"Palathoti","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education and Research,\nOoty, Nilgiris, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"S14459","DOI":"10.4137\/PMC.S14459","volume":"6","author":"Fair R.J.","year":"2014","unstructured":"Fair R.J.; Tor Y.; Antibiotics and bacterial resistance in the 21st century. Perspect Medicinal Chem 2014,6,S14459","journal-title":"Perspect Medicinal Chem"},{"key":"ref=2","year":"2019","unstructured":"CDC\u2019s Antibiotic resistance threats in the United States Centers for Disease Control and PreventionAvailable from:  [Accessed on: November 14, 2021].2019","journal-title":"CDC\u2019s Antibiotic resistance threats in the United States"},{"key":"ref=3","unstructured":"Antibiotic resistance. World Health Organization, 2020. Available from:  [Accessed on: November 14, 2020]."},{"key":"ref=4","unstructured":"Antimicrobial Resistance Threats. National Institute of allergy and Infectious diseases, USA, 2020. Available from:"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"e46416","DOI":"10.1371\/journal.pone.0046416","volume":"7","author":"Hove-Jensen B.","year":"2012","unstructured":"Hove-Jensen B.; McSorley F.R.; Zechel D.L.; Catabolism and detoxification of 1-aminoalkylphosphonic acids: N-acetylation by the phnO gene product. PLoS One 2012,7(10),e46416","journal-title":"PLoS One"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"6150","DOI":"10.1128\/jb.175.19.6150-6157.1993","volume":"175","author":"Mengin-Lecreulx D.","year":"1993","unstructured":"Mengin-Lecreulx D.; van Heijenoort J.; Identification of the glmU gene encoding N-acetylglucosamine-1-phosphate uridyltransferase in Escherichia coli. J Bacteriol 1993,175(19),6150-6157","journal-title":"J Bacteriol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"e61589","DOI":"10.1371\/journal.pone.0061589","volume":"8","author":"Kang J.","year":"2013","unstructured":"Kang J.; Xu L.; Yang S.; Yu W.; Liu S.; Xin Y.; Ma Y.; Effect of phosphoglucosamine mutase on biofilm formation and antimicrobial susceptibilities in M. smegmatis glmM gene knockdown strain. PLoS One 2013,8(4),e61589","journal-title":"PLoS One"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.bbagen.2009.07.018","volume":"1800","author":"Butkinaree C.","year":"2010","unstructured":"Butkinaree C.; Park K.; Hart G.W.; O-linked &#x3B2;-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress. Biochim Biophys Acta 2010,1800(2),96-106","journal-title":"Biochim Biophys Acta"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.abb.2008.01.026","volume":"474","author":"Durand P.","year":"2008","unstructured":"Durand P.; Golinelli-Pimpaneau B.; Mouilleron S.; Badet B.; Badet-Denisot M.A.; Highlights of glucosamine-6P synthase catalysis. Arch Biochem Biophys 2008,474(2),302-317","journal-title":"Arch Biochem Biophys"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"5788","DOI":"10.1128\/jb.176.18.5788-5795.1994","volume":"176","author":"Mengin-Lecreulx D.","year":"1994","unstructured":"Mengin-Lecreulx D.; van Heijenoort J.; Copurification of glucosamine-1-phosphate acetyltransferase and N-acetylglucosamine-1-phosphate uridyltransferase activities of Escherichia coli: Characterization of the glmU gene product as a bifunctional enzyme catalyzing two subsequent steps in the pathway for UDP-N-acetylglucosamine synthesis. J Bacteriol 1994,176(18),5788-5795","journal-title":"J Bacteriol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1074\/jbc.271.1.32","volume":"271","author":"Mengin-Lecreulx D.","year":"1996","unstructured":"Mengin-Lecreulx D.; van Heijenoort J.; Characterization of the essential gene glmM encoding phosphoglucosamine mutase in Escherichia coli. J Biol Chem 1996,271(1),32-39","journal-title":"J Biol Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1021\/bi952275a","volume":"35","author":"Gehring A.M.","year":"1996","unstructured":"Gehring A.M.; Lees W.J.; Mindiola D.J.; Walsh C.T.; Brown E.D.; Acetyltransfer precedes uridylyltransfer in the formation of UDP-N-acetylglucosamine in separable active sites of the bifunctional GlmU protein of Escherichia coli. Biochemistry 1996,35(2),579-585","journal-title":"Biochemistry"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"e43969","DOI":"10.1371\/journal.pone.0043969","volume":"7","author":"Singh V.K.","year":"2012","unstructured":"Singh V.K.; Das K.; Seshadri K.; Kinetic modelling of GlmU reactions - prioritization of reaction for therapeutic application. PLoS One 2012,7(8),e43969","journal-title":"PLoS One"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1002\/bit.24475","volume":"109","author":"Rodr&#xED;guez-D&#xED;az J.","year":"2012","unstructured":"Rodr&#xED;guez-D&#xED;az J.; Rubio-del-Campo A.; Yebra M.J.; Metabolic engineering of Lactobacillus casei for production of UDP-N-acetylglucosamine. Biotechnol Bioeng 2012,109(7),1704-1712","journal-title":"Biotechnol Bioeng"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"14392","DOI":"10.1074\/jbc.273.23.14392","volume":"273","author":"Mio T.","year":"1998","unstructured":"Mio T.; Yabe T.; Arisawa M.; Yamada-Okabe H.; The eukaryotic UDP-N-acetylglucosamine pyrophosphorylases. Gene cloning, protein expression, and catalytic mechanism. J Biol Chem 1998,273(23),14392-14397","journal-title":"J Biol Chem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"16328","DOI":"10.1074\/jbc.M009988200","volume":"276","author":"Peneff C.","year":"2001","unstructured":"Peneff C.; Mengin-Lecreulx D.; Bourne Y.; The crystal structures of Apo and complexed Saccharomyces cerevisiae GNA1 shed light on the catalytic mechanism of an amino-sugar N-acetyltransferase. J Biol Chem [a2001,276(19),16328-16334","journal-title":"J Biol Chem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"6191","DOI":"10.1093\/emboj\/20.22.6191","volume":"20","author":"Peneff C.","year":"2001","unstructured":"Peneff C.; Ferrari P.; Charrier V.; Taburet Y.; Monnier C.; Zamboni V.; Winter J.; Harnois M.; Fassy F.; Bourne Y.; Crystal structures of two human pyrophosphorylase isoforms in complexes with UDPGlc(Gal)NAc: Role of the alternatively spliced insert in the enzyme oligomeric assembly and active site architecture. EMBO J [b2001,20(22),6191-6202","journal-title":"EMBO J"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1016\/j.biocel.2008.05.003","volume":"40","author":"Zhang W.","year":"2008","unstructured":"Zhang W.; Jones V.C.; Scherman M.S.; Mahapatra S.; Crick D.; Bhamidi S.; Xin Y.; McNeil M.R.; Ma Y.; Expression, essentiality, and a microtiter plate assay for mycobacterial GlmU, the bifunctional glucosamine-1-phosphate acetyltransferase and N-acetylglucosamine-1-phosphate uridyltransferase. Int J Biochem Cell Biol 2008,40(11),2560-2571","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1110\/ps.073135107","volume":"16","author":"Mochalkin I.","year":"2007","unstructured":"Mochalkin I.; Lightle S.; Zhu Y.; Ohren J.F.; Spessard C.; Chirgadze N.Y.; Banotai C.; Melnick M.; McDowell L.; Characterization of substrate binding and catalysis in the potential antibacterial target N-acetylglucosamine-1-phosphate uridyltransferase (GlmU). Protein Sci 2007,16(12),2657-2666","journal-title":"Protein Sci"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1021\/bi002503n","volume":"40","author":"Olsen L.R.","year":"2001","unstructured":"Olsen L.R.; Roderick S.L.; Structure of the Escherichia coli GlmU pyrophosphorylase and acetyltransferase active sites. Biochemistry 2001,40(7),1913-1921","journal-title":"Biochemistry"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1110\/ps.072779707","volume":"16","author":"Olsen L.R.","year":"2007","unstructured":"Olsen L.R.; Vetting M.W.; Roderick S.L.; Structure of the E. coli bifunctional GlmU acetyltransferase active site with substrates and products. Protein Sci 2007,16(6),1230-1235","journal-title":"Protein Sci"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.bmcl.2012.01.016","volume":"22","author":"Otterbein L.","year":"2012","unstructured":"Otterbein L.; Breed J.; Ogg D.J.S.; pneumoniae GlmU in complex with an antibacterial inhibitor. Bioorg Med Chem Lett 2012,22,1510","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1107\/S0907444909001036","volume":"65","author":"Zhang Z.","year":"2009","unstructured":"Zhang Z.; Squire C.J.; Baker E.N.; N-acetyl glucosamine 1-phosphate uridyltransferase from Mycobacterium tuberculosis complex with N-acetyl glucosamine 1-phosphate. Acta Crystallogr D Biol Crystallogr 2009,65,275-283","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1110\/ps.073271408","volume":"17","author":"Mochalkin I.","year":"2008","unstructured":"Mochalkin I.; Lightle S.; Narasimhan L.; Bornemeier D.; Melnick M.; Vanderroest S.; McDowell L.; Structure of a small-molecule inhibitor complexed with GlmU from Haemophilus influenzae reveals an allosteric binding site. Protein Sci 2008,17(3),577-582","journal-title":"Protein Sci"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1107\/S1744309109010252","volume":"65","author":"Verma S.K.","year":"2009","unstructured":"Verma S.K.; Jaiswal M.; Kumar N.; Parikh A.; Nandicoori V.K.; Prakash B.; Structure of N-acetylglucosamine-1-phosphate uridyltransferase (GlmU) from Mycobacterium tuberculosis in a cubic space group. Acta Crystallogr Sect F Struct Biol Cryst Commun 2009,65(Pt 5),435-439","journal-title":"Acta Crystallogr Sect F Struct Biol Cryst Commun"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/j.jmb.2013.02.019","volume":"425","author":"Jagtap P.K.","year":"2013","unstructured":"Jagtap P.K.; Verma S.K.; Vithani N.; Bais V.S.; Prakash B.; Crystal structures identify an atypical two-metal-ion mechanism for uridyltransfer in GlmU: Its significance to sugar nucleotidyl transferases. J Mol Biol 2013,425(10),1745-1759","journal-title":"J Mol Biol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1107\/S2053230X14008279","volume":"70","author":"Vithani N.","year":"2014","unstructured":"Vithani N.; Bais V.; Prakash B.; GlmU (N-acetylglucosamine-1-phosphate uridyltransferase) bound to three magnesium ions and ATP at the active site. Acta Crystallogr F Struct Biol Commun 2014,70(Pt 6),703-708","journal-title":"Acta Crystallogr F Struct Biol Commun"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"11844","DOI":"10.1074\/jbc.M011225200","volume":"276","author":"Sulzenbacher G.","year":"2001","unstructured":"Sulzenbacher G.; Gal L.; Peneff C.; Fassy F.; Bourne Y.; Crystal structure of Streptococcus pneumoniae N-acetylglucosamine-1-phosphate uridyltransferase bound to acetyl-coenzyme A reveals a novel active site architecture. J Biol Chem 2001,276(15),11844-11851","journal-title":"J Biol Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1006\/jmbi.2000.4296","volume":"305","author":"Kostrewa D.","year":"2001","unstructured":"Kostrewa D.; D\u2019Arcy A.; Takacs B.; Kamber M.; Crystal structures of Streptococcus pneumoniae N-acetylglucosamine-1-phosphate uridyltransferase, GlmU, in apo form at 2.33 A resolution and in complex with UDP-N-acetylglucosamine and Mg(2+) at 1.96 A resolution. J Mol Biol 2001,305(2),279-289","journal-title":"J Mol Biol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"4799","DOI":"10.1128\/JB.180.18.4799-4803.1998","volume":"180","author":"Pompeo F.","year":"1998","unstructured":"Pompeo F.; van Heijenoort J.; Mengin-Lecreulx D.; Probing the role of cysteine residues in glucosamine-1-phosphate acetyltransferase activity of the bifunctional GlmU protein from Escherichia coli: Site-directed mutagenesis and characterization of the mutant enzymes. J Bacteriol 1998,180(18),4799-4803","journal-title":"J Bacteriol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1128\/jb.105.2.467-471.1971","volume":"105","author":"Sarvas M.","year":"1971","unstructured":"Sarvas M.; Mutant of Escherichia coli K-12 defective in D-glucosamine biosynthesis. J Bacteriol 1971,105(2),467-471","journal-title":"J Bacteriol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1128\/jb.112.2.894-902.1972","volume":"112","author":"Rolls J.P.","year":"1972","unstructured":"Rolls J.P.; Shuster C.W.; Amino sugar assimilation by Escherichia coli. J Bacteriol 1972,112(2),894-902","journal-title":"J Bacteriol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1128\/jb.105.2.455-466.1971","volume":"105","author":"Wu H.C.","year":"1971","unstructured":"Wu H.C.; Wu T.C.; Isolation and characterization of a glucosamine-requiring mutant of Escherichia coli K-12 defective in glucosamine-6-phosphate synthetase. J Bacteriol 1971,105(2),455-466","journal-title":"J Bacteriol"},{"key":"ref=34","author":"Vertesy L.","year":"2004","unstructured":"Vertesy L.; Kurz M.; Markus-Erb A.; Toti L.; 2- Phenylbenzofuran derivatives, a process for preparing them, and their use. U.S. Patent 0,137,254, 2004"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1128\/AAC.01572-08","volume":"53","author":"Pereira M.P.","year":"2009","unstructured":"Pereira M.P.; Blanchard J.E.; Murphy C.; Roderick S.L.; Brown E.D.; High-throughput screening identifies novel inhibitors of the acetyltransferase activity of Escherichia coli GlmU. Antimicrob Agents Chemother 2009,53(6),2306-2311","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"40734","DOI":"10.1074\/jbc.M111.274068","volume":"286","author":"Buurman E.T.","year":"2011","unstructured":"Buurman E.T.; Andrews B.; Gao N.; Hu J.; Keating T.A.; Lahiri S.; Otterbein L.R.; Patten A.D.; Stokes S.S.; Shapiro A.B.; In vitro validation of acetyltransferase activity of GlmU as an antibacterial target in Haemophilus influenzae. J Biol Chem 2011,286(47),40734-40742","journal-title":"J Biol Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.carres.2011.05.024","volume":"346","author":"Li Y.","year":"2011","unstructured":"Li Y.; Zhou Y.; Ma Y.; Li X.; Design and synthesis of novel cell wall inhibitors of Mycobacterium tuberculosis GlmM and GlmU. Carbohydr Res 2011,346(13),1714-1720","journal-title":"Carbohydr Res"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/j.bmcl.2012.01.016","volume":"22","author":"Green O.M.","year":"2012","unstructured":"Green O.M.; McKenzie A.R.; Shapiro A.B.; Otterbein L.; Ni H.; Patten A.; Stokes S.; Albert R.; Kawatkar S.; Breed J.; Inhibitors of acetyltransferase domain of N-acetylglucosamine-1-phosphate-uridyltransferase\/glucosamine-1-phosphate-acetyltransferase (GlmU). Part 1: Hit to lead evaluation of a novel arylsulfonamide series. Bioorg Med Chem Lett 2012,22(4),1510-1519","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"7019","DOI":"10.1016\/j.bmcl.2012.10.003","volume":"22","author":"Stokes S.S.","year":"2012","unstructured":"Stokes S.S.; Albert R.; Buurman E.T.; Andrews B.; Shapiro A.B.; Green O.M.; McKenzie A.R.; Otterbein L.R.; Inhibitors of the acetyltransferase domain of N-acetylglucosamine-1-phosphate-uridylyltransferase\/glucosamine-1-phosphate-acetyltransferase (GlmU). Part 2: Optimization of physical properties leading to antibacterial aryl sulfonamides. Bioorg Med Chem Lett 2012,22(23),7019-7023","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1042\/BJ20120596","volume":"446","author":"Larsen N.A.","year":"2012","unstructured":"Larsen N.A.; Nash T.J.; Morningstar M.; Shapiro A.B.; Joubran C.; Blackett C.J.; Patten A.D.; Boriack-Sjodin P.A.; Doig P.; An aminoquinazoline inhibitor of the essential bacterial cell wall synthetic enzyme GlmU has a unique non-protein-kinase-like binding mode. Biochem J 2012,446(3),405-413","journal-title":"Biochem J"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"6256","DOI":"10.1016\/j.bmc.2014.08.017","volume":"22","author":"Doig P.","year":"2014","unstructured":"Doig P.; Boriack-Sjodin P.A.; Dumas J.; Hu J.; Itoh K.; Johnson K.; Kazmirski S.; Kinoshita T.; Kuroda S.; Sato T.O.; Sugimoto K.; Tohyama K.; Aoi H.; Wakamatsu K.; Wang H.; Rational design of inhibitors of the bacterial cell wall synthetic enzyme GlmU using virtual screening and lead-hopping. Bioorg Med Chem 2014,22(21),6256-6269","journal-title":"Bioorg Med Chem"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"8113","DOI":"10.1039\/c3ob41896k","volume":"11","author":"Tran A.T.","year":"2013","unstructured":"Tran A.T.; Wen D.; West N.P.; Baker E.N.; Britton W.J.; Payne R.J.; Inhibition studies on Mycobacterium tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase (GlmU). Org Biomol Chem 2013,11(46),8113-8126","journal-title":"Org Biomol Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1046\/j.1365-2958.2003.03425.x","volume":"48","author":"Sassetti C.M.","year":"2003","unstructured":"Sassetti C.M.; Boyd D.H.; Rubin E.J.; Genes required for mycobacterial growth defined by high density mutagenesis. Mol Microbiol 2003,48(1),77-84","journal-title":"Mol Microbiol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s00894-015-2704-3","volume":"21","author":"Soni V.","year":"2015","unstructured":"Soni V.; Suryadevara P.; Sriram D.; Kumar S.; Nandicoori V.K.; Yogeeswari P.; Structure-based design of diverse inhibitors of Mycobacterium tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase: Combined molecular docking, dynamic simulation, and biological activity. J Mol Model [a2015,21(7),174","journal-title":"J Mol Model"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"e1005235","DOI":"10.1371\/journal.ppat.1005235","volume":"11","author":"Soni V.","year":"2015","unstructured":"Soni V.; Upadhayay S.; Suryadevara P.; Samla G.; Singh A.; Yogeeswari P.; Sriram D.; Nandicoori V.K.; Depletion of M. tuberculosis GlmU from infected murine lungs effects the clearance of the pathogen. PLoS Pathog [b2015,11(10),e1005235","journal-title":"PLoS Pathog"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.tube.2015.06.003","volume":"95","author":"Rani C.","year":"2015","unstructured":"Rani C.; Mehra R.; Sharma R.; Chib R.; Wazir P.; Nargotra A.; Khan I.A.; High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU. Tuberculosis (Edinb) 2015,95(6),664-677","journal-title":"Tuberculosis (Edinb)"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ejmech.2014.12.030","volume":"92","author":"Mehra R.","year":"2015","unstructured":"Mehra R.; Sharma R.; Khan I.A.; Nargotra A.; Identification and optimization of Escherichia coli GlmU inhibitors: An in silico approach with validation thereof. Eur J Med Chem 2015,92,78-90","journal-title":"Eur J Med Chem"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1021\/acscombsci.5b00019","volume":"18","author":"Mehra R.","year":"2016","unstructured":"Mehra R.; Rani C.; Mahajan P.; Vishwakarma R.A.; Khan I.A.; Nargotra A.; Computationally guided identification of novel Mycobacterium tuberculosis GlmU inhibitory leads, their optimization, and in vitro validation. ACS Comb Sci 2016,18(2),100-116","journal-title":"ACS Comb Sci"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pestbp.2015.01.005","volume":"122","author":"Qi X.","year":"2015","unstructured":"Qi X.; Deng W.; Gao M.; Mao B.; Xu S.; Chen C.; Zhang Q.; Novel lead compound optimization and synthesized based on the target structure of Xanthomonas oryzae pv. oryzae GlmU. Pestic Biochem Physiol 2015,122,22-28","journal-title":"Pestic Biochem Physiol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ejmech.2012.03.051","volume":"53","author":"Min J.","year":"2012","unstructured":"Min J.; Lin D.; Zhang Q.; Zhang J.; Yu Z.; Structure-based virtual screening of novel inhibitors of the uridyltransferase activity of Xanthomonas oryzae pv. oryzae GlmU. Eur J Med Chem 2012,53,150-158","journal-title":"Eur J Med Chem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1007\/s00253-015-7123-y","volume":"100","author":"Sharma R.","year":"2016","unstructured":"Sharma R.; Rani C.; Mehra R.; Nargotra A.; Chib R.; Rajput V.S.; Kumar S.; Singh S.; Sharma P.R.; Khan I.A.; Identification and characterization of novel small molecule inhibitors of the acetyltransferase activity of Escherichia coli N-acetylglucosamine-1-phosphate-uridyltransferase\/glucosamine-1-phosphate-acetyltransferase (GlmU). Appl Microbiol Biotechnol 2016,100(7),3071-3085","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=52","first-page":"320","volume":"33","author":"Yamamoto H.","year":"1980","unstructured":"Yamamoto H.; Moriyama K.; Jinnouchi H.; Yagishita K.; Studies on terreic acid. Jpn J Antibiot 1980,33(3),320-328","journal-title":"Jpn J Antibiot"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1177\/1087057115625308","volume":"21","author":"Sharma R.","year":"2016","unstructured":"Sharma R.; Lambu M.R.; Jamwal U.; Rani C.; Chib R.; Wazir P.; Mukherjee D.; Chaubey A.; Khan I.A.; Escherichia coli N-acetylglucosamine-1-phosphate-uridyltransferase\/glucosamine-1-phosphate-acetyltransferase (GlmU) inhibitory activity of terreic acid isolated from Aspergillus terreus. J Biomol Screen 2016,21(4),342-353","journal-title":"J Biomol Screen"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00203-011-0715-8","volume":"193","author":"Zhou Y.","year":"2011","unstructured":"Zhou Y.; Xin Y.; Sha S.; Ma Y.; Kinetic properties of Mycobacterium tuberculosis bifunctional GlmU. Arch Microbiol 2011,193(10),751-757","journal-title":"Arch Microbiol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3389\/fcimb.2019.00251","volume":"9","author":"Chen C.","year":"2019","unstructured":"Chen C.; Han X.; Yan Q.; Wang C.; Jia L.; Taj A.; Zhao L.; Ma Y.; The inhibitory effect of GlmU acetyltransferase inhibitor TPSA on Mycobacterium tuberculosis may be affected due to its methylation by methyltransferase Rv0560c. Front Cell Infect Microbiol 2019,9,251","journal-title":"Front Cell Infect Microbiol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/jac\/11.5.427","volume":"11","author":"Hall M.J.","year":"1983","unstructured":"Hall M.J.; Middleton R.F.; Westmacott D.; The Fractional Inhibitory Concentration (FIC) index as a measure of synergy. J Antimicrob Chemother 1983,11(5),427-433","journal-title":"J Antimicrob Chemother"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"e02022","DOI":"10.1128\/mBio.02022-16","volume":"8","author":"Sukheja P.","year":"2017","unstructured":"Sukheja P.; Kumar P.; Mittal N.; Li S.G.; Singleton E.; Russo R.; Perryman A.L.; Shrestha R.; Awasthi D.; Husain S.; Soteropoulos P.; Brukh R.; Connell N.; Freundlich J.S.; Alland D.; A novel small-molecule inhibitor of the Mycobacterium tuberculosis demethylmenaquinone methyltransferase MenG is bactericidal to both growing and nutritionally deprived persister cells. MBio 2017,8(1),e02022-e02038","journal-title":"MBio"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1080\/1062936X.2017.1398782","volume":"28","author":"Janardhan S.","year":"2017","unstructured":"Janardhan S.; John L.; Prasanthi M.; Poroikov V.; Narahari Sastry G.A.; QSAR and molecular modelling study towards new lead finding: Polypharmacological approach to Mycobacterium tuberculosis. SAR QSAR Environ Res 2017,28(10),815-832","journal-title":"SAR QSAR Environ Res"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2210-11-5","volume":"11","author":"Singla D.","year":"2011","unstructured":"Singla D.; Anurag M.; Dash D.; Raghava G.P.S.; A web server for predicting inhibitors against bacterial target GlmU protein. BMC Pharmacol 2011,11(1),5","journal-title":"BMC Pharmacol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.3390\/app9142801","volume":"9","author":"Achinas S.","year":"2019","unstructured":"Achinas S.; Charalampogiannis N.; Euverink G.J.W.; A brief recap of microbial adhesion and biofilms. Appl Sci (Basel) 2019,9(14),2801","journal-title":"Appl Sci (Basel)"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3389\/fmicb.2020.00928","volume":"11","author":"Muhammad M.H.","year":"2020","unstructured":"Muhammad M.H.; Idris A.L.; Fan X.; Guo Y.; Yu Y.; Jin X.; Qiu J.; Guan X.; Huang T.; Beyond risk: Bacterial biofilms and their regulating approaches. Front Microbiol 2020,11,928","journal-title":"Front Microbiol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/2049-632X.12141","volume":"70","author":"Chung P.Y.","year":"2014","unstructured":"Chung P.Y.; Toh Y.S.; Anti-biofilm agents: Recent breakthrough against multi-drug resistant Staphylococcus aureus. Pathog Dis 2014,70(3),231-239","journal-title":"Pathog Dis"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"898","DOI":"10.3389\/fmicb.2018.00898","volume":"9","author":"Gali&#xE9; S.","year":"2018","unstructured":"Gali&#xE9; S.; Garc&#xED;a-Guti&#xE9;rrez C.; Migu&#xE9;lez E.M.; Villar C.J.; Lomb&#xF3; F.; Biofilms in the food industry: Health aspects and control methods. Front Microbiol 2018,9,898","journal-title":"Front Microbiol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0014-827X(02)01217-X","volume":"57","author":"Zentz F.","year":"2002","unstructured":"Zentz F.; Valla A.; Le Guillou R.; Labia R.; Mathot A.G.; Sirot D.; Synthesis and antimicrobial activities of N-substituted imides. Farmaco 2002,57(5),421-426","journal-title":"Farmaco"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1128\/AAC.50.5.1835-1840.2006","volume":"50","author":"Burton E.","year":"2006","unstructured":"Burton E.; Gawande P.V.; Yakandawala N.; LoVetri K.; Zhanel G.G.; Romeo T.; Friesen A.D.; Madhyastha S.; Antibiofilm activity of GlmU enzyme inhibitors against catheter-associated uropathogens. Antimicrob Agents Chemother 2006,50(5),1835-1840","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"387","DOI":"10.4103\/0019-5359.108954","volume":"65","author":"Suman E.","year":"2011","unstructured":"Suman E.; D\u2019souza S.J.; Jacob P.; Sushruth M.R.; Kotian M.S.; Anti-biofilm and anti-adherence activity of Glm-U inhibitors. Indian J Med Sci 2011,65(9),387-392","journal-title":"Indian J Med Sci"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1128\/mr.56.3.395-411.1992","volume":"56","author":"Vaara M.","year":"1992","unstructured":"Vaara M.; Agents that increase the permeability of the outer membrane. Microbiol Rev 1992,56(3),395-411","journal-title":"Microbiol Rev"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"e00200","DOI":"10.1128\/AAC.00200-17","volume":"61","author":"Corbett D.","year":"2017","unstructured":"Corbett D.; Wise A.; Langley T.; Skinner K.; Trimby E.; Birchall S.; Dorali A.; Sandiford S.; Williams J.; Warn P.; Vaara M.; Lister T.; Potentiation of antibiotic activity by a novel cationic peptide: Potency and spectrum of activity of SPR741. Antimicrob Agents Chemother 2017,61(8),e00200-e00217","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"e01239","DOI":"10.1128\/AAC.01239-17","volume":"61","author":"Zurawski D.V.","year":"2017","unstructured":"Zurawski D.V.; Reinhart A.A.; Alamneh Y.A.; Pucci M.J.; Si Y.; Abu-Taleb R.; Shearer J.P.; Demons S.T.; Tyner S.D.; Lister T.; SPR741, an antibiotic adjuvant, potentiates the in vitro and in vivo activity of rifampin against clinically relevant extensively drug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2017,61(12),e01239-e17","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/nyas.12024","volume":"1277","author":"Page M.G.","year":"2013","unstructured":"Page M.G.; Siderophore conjugates. Ann N Y Acad Sci 2013,1277(1),115-126","journal-title":"Ann N Y Acad Sci"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/S0968-0896(02)00044-5","volume":"10","author":"Wittmann S.","year":"2002","unstructured":"Wittmann S.; Schnabelrauch M.; Scherlitz-Hofmann I.; M&#xF6;llmann U.; Ankel-Fuchs D.; Heinisch L.; New synthetic siderophores and their beta-lactam conjugates based on diamino acids and dipeptides. Bioorg Med Chem 2002,10(6),1659-1670","journal-title":"Bioorg Med Chem"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.tips.2014.06.007","volume":"35","author":"G&#xF3;rska A.","year":"2014","unstructured":"G&#xF3;rska A.; Sloderbach A.; Marsza\u0142; M.P. Siderophore-drug complexes: Potential medicinal applications of the \u2018Trojan horse\u2019 strategy. Trends Pharmacol Sci 2014,35(9),442-449","journal-title":"Trends Pharmacol Sci"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1021\/bc300610f","volume":"24","author":"Wencewicz T.A.","year":"2013","unstructured":"Wencewicz T.A.; Long T.E.; M&#xF6;llmann U.; Miller M.J.; Trihydroxamate siderophore-fluoroquinolone conjugates are selective sideromycin antibiotics that target Staphylococcus aureus. Bioconjug Chem 2013,24(3),473-486","journal-title":"Bioconjug Chem"}],"container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389557522666220817114445","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/207587\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389557522666220817114445","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T05:09:29Z","timestamp":1680152969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/207587\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389557522666220817114445","relation":{},"ISSN":["1389-5575"],"issn-type":[{"value":"1389-5575","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-02-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}